耳鼻咽喉科・頭頸部外科90巻10号

2018年09月発行

特集 どこが変わった頭頸部癌診療ガイドライン

放射線治療

著者： 古平毅¹

所属機関： ¹愛知県がんセンター中央病院放射線治療部

ページ範囲：P.850 - P.854

文献概要

POINT

放射線治療での主な変更点は以下の通りである。

●「治療総論」が新設された。

●CQ12として放射線治療のクリニカルクエスチョン（CQ）が独立した。

●CQ12-3（化学放射線療法後の救済手術），CQ12-4（化学放射線療法後の再照射）が新設された。

●CQ12-1（術後化学放射線療法），CQ12-2（強度変調放射線治療）が修正され，CQ12-5〜CQ12-7では粒子線治療を細分化して解説された。

参考文献

1）Bourhis J, et al：Hyperfractionated or accelerated radiotherapy in head and neck cancer：a meta-analysis. Lancet 368：843-854, 2006

2）Yamazaki H, et al：Radiotherapy for early glottic carcinoma（T1N0M0）：results of prospective randomized study of radiation fraction size and overall treatment time. Int J Radiat Oncol Biol Phys 64：77-82, 2006

3）Kodaira T, et al：Results of a multi-institutional, randomized, non-inferiority, phase Ⅲ trial of accelerated fractionation versus standard fractionation in radiation therapy for T1-2N0M0 glottic cancer：Japan Clinical Oncology Group study（JCOG0701）. Ann Oncol 29：992-997, 2018

4）Ferris RL, et al：Nivolumab for recurrent squamous-cell carcinoma of the head and neck. N Engl J Med 375：1856-1867, 2016

5）Bernier J, et al：Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 350：1945-1952, 2004

6）Cooper JS, et al：Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 350：1937-1944, 2004

7）Bernier J, et al：Defining risk levels in locally advanced head and neck cancers：a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC（#22931）and RTOG（#9501）. Head Neck 27：843-850, 2005

8）Marta GN, et al：Intensity-modulated radiation therapy for head and neck cancer：systematic review and meta-analysis. Radiother Oncol 110：9-15, 2014

9）Tribius S, et al：Residual deficits in quality of life one year after intensity-modulated radiotherapy for patients with locally advanced head and neck cancer：results of a prospective study. Strahlenther Onkol 191：501-510, 2015

10）Chen AM, et al：Practical considerations in the re-irradiation of recurrent and second primary head-and-neck cancer：who, why, how, and how much? Int J Radiat Oncol Biol Phys 81：1211-1219, 2011

11）Yamazaki H, et al：Frequency, outcome and prognostic factors of carotid blowout syndrome after hypofractionated re-irradiation of head and neck cancer using CyberKnife：a multi-institutional study. Radiother Oncol 107：305-309, 2013

12）Paulino AC, et al：Long-term effects in children treated with radiotherapy for head and neck rhabdomyosarcoma. Int J Radiat Oncol Biol Phys 48：1489-1495, 2000

13）Patel SH, et al：Charged particle therapy versus photon therapy for paranasal sinus and nasal cavity malignant diseases：a systematic review and meta-analysis. Lancet Oncol 15：1027-1038, 2014

14）Demizu Y, et al：Analysis of vision loss caused by radiation-induced optic neuropathy after particle therapy for head-and-neck and skull-base tumors adjacent to optic nerves. Int J Radiat Oncol Biol Phys 75：1487-1492, 2009

15）Jingu K, et al：Carbon ion radiation therapy improves the prognosis of unresectable adult bone and soft-tissue sarcoma of the head and neck. Int J Radiat Oncol Biol Phys 82：2125-2131, 2012

16）Uhl M, et al：High control rate in patients with chondrosarcoma of the skull base after carbon ion therapy：first report of long-term results. Cancer 120：1579-1585, 2014

17）Bloch OG, et al：A systematic review of intracranial chondrosarcoma and survival. J Clin Neurosci 16：1547-1551, 2009